Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MYC amplification + BCL2 amplification + TNFRSF8 expression
i
Other names:
MYC, bHLHe39, c-Myc, MYCC, V-myc avian myelocytomatosis viral oncogene homolog, BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2, TNFRSF8, TNF Receptor Superfamily Member 8, Tumor Necrosis Factor Receptor Superfamily Member 8, Lymphocyte Activation Antigen CD30, CD30L Receptor, Ki-1 Antigen, D1S166E, CD30, Tumor Necrosis Factor Receptor Superfamily, Member 8, Cytokine Receptor CD30, CD30 Antigen, TNFRSF8, Ki-1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4609
;
596
;
943
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
MYC-IGH fusion (3)
IL7R-BCL2 fusion (1)
MYC-BCL2 fusion (0)
BCL2 fusion (0)
MYC-IGH fusion (3)
IL7R-BCL2 fusion (1)
MYC-BCL2 fusion (0)
BCL2 fusion (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MYC amplification + BCL2 amplification + TNFRSF8 expression
Diffuse Large B Cell Lymphoma
MYC amplification + BCL2 amplification + TNFRSF8 expression
Diffuse Large B Cell Lymphoma
brentuximab vedotin
Sensitive: C4 – Case Studies
brentuximab vedotin
Sensitive
:
C4
brentuximab vedotin
Sensitive: C4 – Case Studies
brentuximab vedotin
Sensitive
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.